ASTRID PHARMA

Astrid Pharma Inc, an early-stage biotech firm, pioneers the BioCapZ technology platform for safe and efficient drug delivery, accommodating various drug classes from small molecules to biologics. Technology Advantages: BioCapZ, based on the patented virus capsid, excels over competitors entering the body without triggering the immune system. A stealth delivery system technology. Astrid's business model involves partnerships and licensing deals to generate immediate revenues. Internal product development efforts focus on the BioCapZ platform, ensuring maximum value retention. Revenues from partnerships de-risk the company, while internal development efforts maximize technology platform value.